Disclosures for "Efficacy and Safety of Targeted Immunotherapy with ANX005 in Treating Guillain-Barré Syndrome: A Phase 3 Multicenter Study"
-
Dr. Kroon has received personal compensation for serving as an employee of Annexon Biosciences. Dr. Kroon has stock in Annexon Biosciences.
-
Zhahirul Islam has nothing to disclose.
-
Peter Collins has received personal compensation for serving as an employee of Annexon Biosciences. An immediate family member of Peter Collins has received personal compensation for serving as an employee of Wikipedia.
-
Benjamin Hoehn has received personal compensation for serving as an employee of Annexon.
-
Eric Humphriss has received personal compensation for serving as an employee of Annexon Biosciences. Eric Humphriss has stock in Annexon Biosciences.
-
Ms. Lin has nothing to disclose.
-
Dr. Morrison has received personal compensation for serving as an employee of Alector. Dr. Morrison has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG . Dr. Morrison has stock in Alector. Dr. Morrison has received intellectual property interests from a discovery or technology relating to health care.
-
Author has nothing to disclose
-
Prof. Azad has nothing to disclose.
-
Dr. Artis has received personal compensation for serving as an employee of Annexon Biosciences. Dr. Artis has stock in Annexon Biosciences.
-
Ted Yednock, PhD has received personal compensation for serving as an employee of Annexon Inc. Ted Yednock, PhD has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Annexon Inc. Ted Yednock, PhD has stock in Annexon Inc. Ted Yednock, PhD has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Deen Mohammad has nothing to disclose.